Valisena S, Varaldo P E, Satta G
Istituto di Microbiologia, Università degli Studi di Padova, Italy.
J Clin Invest. 1991 Jun;87(6):1969-76. doi: 10.1172/JCI115224.
The effect of a bacteriolytic enzyme, the endo-beta-N-acetylglucosaminidase excreted by Staphylococcus aureus (SaG) on the response of human lymphocytes to mitogens and on the immune response in mice has been studied. SaG inhibited incorporation of [3H]thymidine into TCA-precipitable material by human peripheral lymphocytes stimulated either by phytohemagglutinin or by concanavalin A, as well as formation of cytoplasmic immunoglobulin-containing cells by B lymphocytes treated with pokeweed mitogen. In all cases the level of inhibition first increased with the SaG concentrations reaching values of over 80% at an enzyme concentration of 100 micrograms/ml, and then decreased. Heat-inactivated SaG as well as SaG treated with both polyclonal and monoclonal specific antibodies or enzyme inhibitors such as chitotriose or hydrolyzed peptidoglycan had no effect on lymphocyte response to mitogens. In mice, SaG at a dose of 300 micrograms per mouse was found to cause a fourfold decrease in the anti-BSA antibody titer and an approximately 70-75% reduction in the immunoglobulin-containing cells in the spleens of mice injected with sheep red blood cells. SaG also completely abolished the enhancing effect of adjuvants such as muramyldipeptide, Freund's complete adjuvant, and Escherichia coli lipopolysaccharide. When SaG was injected into mice together with S. aureus peptidoglycan hydrolyzed either by SaG or by human lysozyme, the inhibitory effect on both production of anti-BSA circulating antibodies and appearance of Igc cells in the spleens of mice injected with sheep red blood cells was enhanced. As we know that (a) human tissues contain endo-beta-N-acetylglucosaminidases; (b) other human hexosaminidases (lysozymes) have previously been shown to interfere with the functions of immunocompetent cells; and (c) products of hexosaminidase hydrolysis of peptidoglycan (muropeptides) known to modulate immune response are ordinarily found in the urine of healthy persons, the possibility that hexosaminidases play a major role in the regulation of the immune response is raised and discussed.
研究了一种溶菌酶,即金黄色葡萄球菌分泌的内切-β-N-乙酰氨基葡萄糖苷酶(SaG)对人淋巴细胞对有丝分裂原的反应以及对小鼠免疫反应的影响。SaG抑制[3H]胸腺嘧啶核苷掺入由植物血凝素或伴刀豆球蛋白A刺激的人外周淋巴细胞的三氯乙酸沉淀物质中,以及抑制由商陆有丝分裂原处理的B淋巴细胞形成含细胞质免疫球蛋白的细胞。在所有情况下,抑制水平首先随着SaG浓度的增加而升高,在酶浓度为100微克/毫升时达到超过80%的值,然后下降。热灭活的SaG以及用多克隆和单克隆特异性抗体或酶抑制剂(如壳三糖或水解肽聚糖)处理的SaG对淋巴细胞对有丝分裂原的反应没有影响。在小鼠中,发现每只小鼠注射300微克的SaG会导致抗牛血清白蛋白抗体滴度降低四倍,并且在注射绵羊红细胞的小鼠脾脏中含免疫球蛋白的细胞减少约70-75%。SaG还完全消除了诸如胞壁酰二肽、弗氏完全佐剂和大肠杆菌脂多糖等佐剂的增强作用。当将SaG与经SaG或人溶菌酶水解的金黄色葡萄球菌肽聚糖一起注射到小鼠中时,对注射绵羊红细胞的小鼠脾脏中抗牛血清白蛋白循环抗体的产生和Igc细胞的出现的抑制作用增强。鉴于我们知道(a)人体组织含有内切-β-N-乙酰氨基葡萄糖苷酶;(b)先前已表明其他人类己糖胺酶(溶菌酶)会干扰免疫活性细胞的功能;以及(c)已知调节免疫反应的肽聚糖己糖胺酶水解产物(胞壁肽)通常存在于健康人的尿液中,因此提出并讨论了己糖胺酶在免疫反应调节中起主要作用的可能性。